Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV Vaccines
Second IAVI-Sponsored Vaccine For Africa Enters Human Trials In U.K.
April 11th, 2001
The second International AIDS Vaccine Initiative (IAVI-) sponsored preventive HIV vaccine designed specifically for Africa entered human trials on March 14, 2001, in the U.K. with the inoculation of five volunteers. Testing of the vaccine will begin later in Kenya. The MVA, or modified vaccinia Ankara, vaccine is the first of its kind to be tested in humans. Derived from a virus used in smallpox immunization, the vaccine aims to stimulate the production of a certain kind of immune cell that kills other cells infected with HIV. The vaccine is attenuated through genetic modification so it cannot cause infection with either HIV or pox...
Source: Vaccine Weekly (2001-04-11)
|
